全球止血劑市場，2025-2029年

全球止血劑市場預計從 2024 年到 2029 年將成長 9.109 億美元，預測期內複合年成長率為 5.8%。

本報告對全球止血劑市場進行了全面分析，包括市場規模和預測、趨勢、成長要素和挑戰，以及對約 25 家公司的供應商分析。

該報告對當前市場狀況、最新趨勢和促進因素以及整體市場環境進行了最新分析，其促進因素包括外科手術數量的增加、對研發的日益重視以及運動相關損傷和脊柱疾病發病率的上升。

本研究採用客觀的方法，結合一手和二手訊息，包括來自主要行業相關人員的意見。報告包含全面的市場規模數據、區域細分分析、供應商格局以及對主要企業的分析。報告提供歷史數據和預測數據。

研究指出，醫院和手術中心的增加是未來幾年推動全球止血劑市場成長的主要因素之一。此外，人們越來越重視有效控制手術患者的出血，新興市場對先進止血劑的需求不斷成長，預計也將顯著提升市場需求。

目錄

第1章執行摘要

第2章 Technavio 分析

• 價格、生命週期、顧客購買籃、採用率和購買標準分析
• 投入與差異化因素的重要性
• 混淆來源
• 促進因素和挑戰的影響

第3章 市場情勢

• 市場生態系統
• 市場特徵
• 價值鏈分析

第4章 市場規模

• 市場定義
• 市場區隔分析
• 2024年市場規模
• 2024-2029年市場展望

第5章 市場規模表現

• 2019-2023年全球止血劑市場
• 2019-2023年醫藥產業細分市場分析
• 2019-2023年產品類型細分市場分析
• 2019-2023年最終用戶細分市場分析
• 2019-2023年區域細分市場分析
• 2019-2023年國家細分市場分析

第6章 定性分析

• 人工智慧的影響：全球止血劑市場

第7章五力分析

• 五力分析概述
• 買方的議價能力
• 供應商的議價能力
• 新進入者的威脅
• 替代品的威脅
• 競爭威脅
• 市場狀況

8. 按配方進行市場區隔

• 比較：按配方
• 基質凝膠
• 座墊
• 海綿
• 粉末
• 按配方分類的市場機會

9. 依產品類型進行市場區隔

• 比較：依產品類型
• 基於凝血酶的止血劑
• 明膠基止血劑
• 膠原蛋白蛋白止血劑
• 按產品類型分類的市場機會

第10章 按最終用戶進行市場細分

• 比較：按最終用戶
• 醫院
• 門診手術中心（ASC）
• 專科診所
• 按最終用戶分類的市場機會

第11章 客戶情況

第12章 區域情勢

• 區域細分
• 區域比較
• 北美洲
  • 美國
  • 加拿大
  • 墨西哥
• 歐洲
  • 德國
  • 英國
  • 法國
  • 義大利
  • 西班牙
  • 荷蘭
• 亞洲
  • 中國
  • 印度
  • 日本
  • 韓國
  • 印尼
  • 泰國
• 世界其他地區
  • 巴西
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 土耳其
  • 阿根廷
  • 哥倫比亞
  • 南非
  • 以色列
• 各區域的市場機遇

第13章：促進因素、挑戰與機遇

• 市場促進因素
• 市場挑戰
• 促進因素和挑戰的影響
• 市場機遇

第14章 競爭格局

• 概述
• 競爭格局
• 令人困惑的局面
• 產業風險

第15章 競爭分析

• 公司簡介
• 企業排名指數
• 公司市場定位
• Aegis Lifesciences Pvt. Ltd.
• Artivion Inc.
• Axio Biosolutions Pvt. Ltd.
• B.Braun SE
• Baxter International Inc.
• Becton Dickinson and Co.
• CuraMedical BV
• Grayline Medical Inc.
• Johnson and Johnson Services
• MBP Medical Biomaterial Products GmbH
• STERIS plc
• Ted Pella Inc.
• Towne Brothers Pvt. Ltd.
• World Precision Instruments
• Ydm Corp.

第16章附錄

The global hemostats market is forecasted to grow by USD 910.9 mn during 2024-2029, accelerating at a CAGR of 5.8% during the forecast period. The report on the global hemostats market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by growing volume of surgical procedures performed, rising focus on research and development, increasing incidence of sports-related injuries and spinal ailments.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.

Technavio's global hemostats market is segmented as below:

By Formulation

• Matrix and gels
• Sheet and pad
• Sponge
• Powder

By Product Type

• Thrombin-based hemostats
• Gelatin-based hemostats
• Collagen-based hemostats

By End-User

• Hospitals
• ASCs
• Specialty clinics

Geography

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
• Asia
• Rest of World (ROW)
• Rest of World (ROW)

This study identifies the rise in number of hospitals and surgical centers as one of the prime reasons driving the global hemostats market growth during the next few years. Also, rising focus on effective blood loss management in patients during surgeries and growing adoption of advanced hemostats in emerging markets will lead to sizable demand in the market.

The report on the global hemostats market covers the following areas:

• Global hemostats market sizing
• Global hemostats market forecast
• Global hemostats market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading global hemostats market vendors that include Aegis Lifesciences Pvt. Ltd., Artivion Inc., Axio Biosolutions Pvt. Ltd., B.Braun SE, Baxter International Inc., Becton Dickinson and Co., CuraMedical BV, Gelita AG, Grayline Medical Inc., Integra LifeSciences Corp., Johnson and Johnson Services, MBP Medical Biomaterial Products GmbH, Pfizer Inc., STERIS plc, Ted Pella Inc., Teleflex Inc., Towne Brothers Pvt. Ltd., World Precision Instruments, Ydm Corp.. Also, the global hemostats market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

1 Executive Summary

• 1.1 Market overview
  • Executive Summary - Chart on Market Overview
  • Executive Summary - Data Table on Market Overview
  • Executive Summary - Chart on Global Market Characteristics
  • Executive Summary - Chart on Market by Geography
  • Executive Summary - Chart on Market Segmentation by Formulation
  • Executive Summary - Chart on Market Segmentation by Product Type
  • Executive Summary - Chart on Market Segmentation by End-user
  • Executive Summary - Chart on Incremental Growth
  • Executive Summary - Data Table on Incremental Growth
  • Executive Summary - Chart on Company Market Positioning

2 Technavio Analysis

• 2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
  • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 2.2 Criticality of inputs and Factors of differentiation
• 2.3 Factors of disruption
• 2.4 Impact of drivers and challenges

3 Market Landscape

• 3.1 Market ecosystem
• 3.2 Market characteristics
• 3.3 Value chain analysis

4 Market Sizing

• 4.1 Market definition
• 4.2 Market segment analysis
  • Market segments
• 4.3 Market size 2024
• 4.4 Market outlook: Forecast for 2024-2029

5 Historic Market Size

• 5.1 Global Hemostats Market 2019 - 2023
  • Historic Market Size - Data Table on Global Hemostats Market 2019 - 2023 ($ million)
• 5.2 Formulation segment analysis 2019 - 2023
  • Historic Market Size - Formulation Segment 2019 - 2023 ($ million)
• 5.3 Product Type segment analysis 2019 - 2023
  • Historic Market Size - Product Type Segment 2019 - 2023 ($ million)
• 5.4 End-user segment analysis 2019 - 2023
  • Historic Market Size - End-user Segment 2019 - 2023 ($ million)
• 5.5 Geography segment analysis 2019 - 2023
  • Historic Market Size - Geography Segment 2019 - 2023 ($ million)
• 5.6 Country segment analysis 2019 - 2023
  • Historic Market Size - Country Segment 2019 - 2023 ($ million)

6 Qualitative Analysis

• 6.1 The AI impact on Global Hemostats Market

7 Five Forces Analysis

• 7.1 Five forces summary
  • Five forces analysis - Comparison between 2024 and 2029
• 7.2 Bargaining power of buyers
  • Bargaining power of buyers - Impact of key factors 2024 and 2029
• 7.3 Bargaining power of suppliers
  • Bargaining power of suppliers - Impact of key factors in 2024 and 2029
• 7.4 Threat of new entrants
  • Threat of new entrants - Impact of key factors in 2024 and 2029
• 7.5 Threat of substitutes
  • Threat of substitutes - Impact of key factors in 2024 and 2029
• 7.6 Threat of rivalry
  • Threat of rivalry - Impact of key factors in 2024 and 2029
• 7.7 Market condition

8 Market Segmentation by Formulation

• 8.1 Market segments
• 8.2 Comparison by Formulation
• 8.3 Matrix and gels - Market size and forecast 2024-2029
• 8.4 Sheet and pad - Market size and forecast 2024-2029
• 8.5 Sponge - Market size and forecast 2024-2029
• 8.6 Powder - Market size and forecast 2024-2029
• 8.7 Market opportunity by Formulation
  • Market opportunity by Formulation ($ million)

9 Market Segmentation by Product Type

• 9.1 Market segments
• 9.2 Comparison by Product Type
• 9.3 Thrombin-based hemostats - Market size and forecast 2024-2029
• 9.4 Gelatin-based hemostats - Market size and forecast 2024-2029
• 9.5 Collagen-based hemostats - Market size and forecast 2024-2029
• 9.6 Market opportunity by Product Type
  • Market opportunity by Product Type ($ million)

10 Market Segmentation by End-user

• 10.1 Market segments
• 10.2 Comparison by End-user
• 10.3 Hospitals - Market size and forecast 2024-2029
• 10.4 ASCs - Market size and forecast 2024-2029
• 10.5 Specialty clinics - Market size and forecast 2024-2029
• 10.6 Market opportunity by End-user
  • Market opportunity by End-user ($ million)

11 Customer Landscape

• 11.1 Customer landscape overview
  • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

12 Geographic Landscape

• 12.1 Geographic segmentation
• 12.2 Geographic comparison
• 12.3 North America - Market size and forecast 2024-2029
  • 12.3.1 US - Market size and forecast 2024-2029
  • 12.3.2 Canada - Market size and forecast 2024-2029
  • 12.3.3 Mexico - Market size and forecast 2024-2029
• 12.4 Europe - Market size and forecast 2024-2029
  • 12.4.1 Germany - Market size and forecast 2024-2029
  • 12.4.2 UK - Market size and forecast 2024-2029
  • 12.4.3 France - Market size and forecast 2024-2029
  • 12.4.4 Italy - Market size and forecast 2024-2029
  • 12.4.5 Spain - Market size and forecast 2024-2029
  • 12.4.6 The Netherlands - Market size and forecast 2024-2029
• 12.5 Asia - Market size and forecast 2024-2029
  • 12.5.1 China - Market size and forecast 2024-2029
  • 12.5.2 India - Market size and forecast 2024-2029
  • 12.5.3 Japan - Market size and forecast 2024-2029
  • 12.5.4 South Korea - Market size and forecast 2024-2029
  • 12.5.5 Indonesia - Market size and forecast 2024-2029
  • 12.5.6 Thailand - Market size and forecast 2024-2029
• 12.6 Rest of World (ROW) - Market size and forecast 2024-2029
  • 12.6.1 Brazil - Market size and forecast 2024-2029
  • 12.6.2 Saudi Arabia - Market size and forecast 2024-2029
  • 12.6.3 UAE - Market size and forecast 2024-2029
  • 12.6.4 Turkey - Market size and forecast 2024-2029
  • 12.6.5 Argentina - Market size and forecast 2024-2029
  • 12.6.6 Colombia - Market size and forecast 2024-2029
  • 12.6.7 South Africa - Market size and forecast 2024-2029
  • 12.6.8 Israel - Market size and forecast 2024-2029
• 12.7 Market opportunity by geography
  • Market opportunity by geography ($ million)
  • Data Tables on Market opportunity by geography ($ million)

13 Drivers, Challenges, and Opportunity

• 13.1 Market drivers
  • Growing volume of surgical procedures performed
  • Rising focus on research and development
  • Increasing incidence of sports-related injuries and spinal ailments
• 13.2 Market challenges
  • Dearth of medical personnel skilled in effective use of hemostat products
  • High cost of surgical procedures
  • Clinical and other limitations associated with hemostat products
• 13.3 Impact of drivers and challenges
  • Impact of drivers and challenges in 2024 and 2029
• 13.4 Market opportunities
  • Rise in number of hospitals and surgical centers
  • Rising focus on effective blood loss management in patients during surgeries
  • Growing adoption of advanced hemostats in emerging markets

14 Competitive Landscape

• 14.1 Overview
• 14.2 Competitive Landscape
  • Overview on criticality of inputs and factors of differentiation
• 14.3 Landscape disruption
  • Overview on factors of disruption
• 14.4 Industry risks
  • Impact of key risks on business

15 Competitive Analysis

• 15.1 Companies profiled
  • Companies covered
• 15.2 Company ranking index
  • Company ranking index
• 15.3 Market positioning of companies
  • Matrix on companies position and classification
• 15.4 Aegis Lifesciences Pvt. Ltd.
  • Aegis Lifesciences Pvt. Ltd. - Overview
  • Aegis Lifesciences Pvt. Ltd. - Product / Service
  • Aegis Lifesciences Pvt. Ltd. - Key offerings
  • SWOT
• 15.5 Artivion Inc.
  • Artivion Inc. - Overview
  • Artivion Inc. - Business segments
  • Artivion Inc. - Key offerings
  • Artivion Inc. - Segment focus
  • SWOT
• 15.6 Axio Biosolutions Pvt. Ltd.
  • Axio Biosolutions Pvt. Ltd. - Overview
  • Axio Biosolutions Pvt. Ltd. - Product / Service
  • Axio Biosolutions Pvt. Ltd. - Key offerings
  • SWOT
• 15.7 B.Braun SE
  • B.Braun SE - Overview
  • B.Braun SE - Product / Service
  • B.Braun SE - Key news
  • B.Braun SE - Key offerings
  • SWOT
• 15.8 Baxter International Inc.
  • Baxter International Inc. - Overview
  • Baxter International Inc. - Business segments
  • Baxter International Inc. - Key news
  • Baxter International Inc. - Key offerings
  • Baxter International Inc. - Segment focus
  • SWOT
• 15.9 Becton Dickinson and Co.
  • Becton Dickinson and Co. - Overview
  • Becton Dickinson and Co. - Business segments
  • Becton Dickinson and Co. - Key news
  • Becton Dickinson and Co. - Key offerings
  • Becton Dickinson and Co. - Segment focus
  • SWOT
• 15.10 CuraMedical BV
  • CuraMedical BV - Overview
  • CuraMedical BV - Product / Service
  • CuraMedical BV - Key offerings
  • SWOT
• 15.11 Grayline Medical Inc.
  • Grayline Medical Inc. - Overview
  • Grayline Medical Inc. - Product / Service
  • Grayline Medical Inc. - Key offerings
  • SWOT
• 15.12 Johnson and Johnson Services
  • Johnson and Johnson Services - Overview
  • Johnson and Johnson Services - Business segments
  • Johnson and Johnson Services - Key news
  • Johnson and Johnson Services - Key offerings
  • Johnson and Johnson Services - Segment focus
  • SWOT
• 15.13 MBP Medical Biomaterial Products GmbH
  • MBP Medical Biomaterial Products GmbH - Overview
  • MBP Medical Biomaterial Products GmbH - Product / Service
  • MBP Medical Biomaterial Products GmbH - Key offerings
  • SWOT
• 15.14 STERIS plc
  • STERIS plc - Overview
  • STERIS plc - Business segments
  • STERIS plc - Key news
  • STERIS plc - Key offerings
  • STERIS plc - Segment focus
  • SWOT
• 15.15 Ted Pella Inc.
  • Ted Pella Inc. - Overview
  • Ted Pella Inc. - Product / Service
  • Ted Pella Inc. - Key offerings
  • SWOT
• 15.16 Towne Brothers Pvt. Ltd.
  • Towne Brothers Pvt. Ltd. - Overview
  • Towne Brothers Pvt. Ltd. - Product / Service
  • Towne Brothers Pvt. Ltd. - Key offerings
  • SWOT
• 15.17 World Precision Instruments
  • World Precision Instruments - Overview
  • World Precision Instruments - Product / Service
  • World Precision Instruments - Key offerings
  • SWOT
• 15.18 Ydm Corp.
  • Ydm Corp. - Overview
  • Ydm Corp. - Product / Service
  • Ydm Corp. - Key offerings
  • SWOT

16 Appendix

• 16.1 Scope of the report
  • Market definition
  • Objectives
  • Notes and caveats
• 16.2 Inclusions and exclusions checklist
  • Inclusions checklist
  • Exclusions checklist
• 16.3 Currency conversion rates for US$
  • Currency conversion rates for US$
• 16.4 Research methodology
  • Research methodology
• 16.5 Data procurement
  • Information sources
• 16.6 Data validation
  • Data validation
• 16.7 Validation techniques employed for market sizing
  • Validation techniques employed for market sizing
• 16.8 Data synthesis
  • Data synthesis
• 16.9 360 degree market analysis
  • 360 degree market analysis
• 16.10 List of abbreviations
  • List of abbreviations